Intraoperative Testing of Colorectal Anastomosis - Air or Water (Methylene Blue)?
Launched by MEIR MEDICAL CENTER · Oct 17, 2017
Trial Information
Current as of June 28, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over the age of 18 undergoing elective colonic resection of their distal part of the colon/ rectum with colorectal anastomosis in a laparoscopic or open approach for a benign or malignant colonic disease.
- Exclusion Criteria:
- • Emergent colonic resections,
- • Colonic resections with no colorectal anastamosis
About Meir Medical Center
Meir Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a prominent sponsor of clinical studies, Meir Medical Center is committed to fostering collaboration among healthcare professionals, researchers, and patients to explore new therapies and treatment modalities. With a focus on ethical practices and patient safety, the center aims to contribute significantly to the scientific community while enhancing the quality of care provided to its diverse patient population. Through its robust infrastructure and multidisciplinary approach, Meir Medical Center stands at the forefront of medical innovation, driving progress in various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Shmuel Avital, MD
Principal Investigator
Meir Medical Center, Israel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials